hygromycin-a and Lung-Neoplasms

hygromycin-a has been researched along with Lung-Neoplasms* in 4 studies

Other Studies

4 other study(ies) available for hygromycin-a and Lung-Neoplasms

ArticleYear
Induction of microsatellite mutations by oxidative agents in human lung cancer cell lines.
    Carcinogenesis, 2000, Volume: 21, Issue:8

    Genomic instability has been associated with cancer development. Oxidative DNA damage seems to contribute to genetic instability observed in cancer. We have used human lung cancer cell lines carrying a plasmid vector containing a (CA)(13) microsatellite sequence to study frameshift mutations mediated by ROS-generating chemicals paraquat and hydrogen peroxide. Exposure of the cells to both paraquat and hydrogen peroxide resulted in significantly higher mutation frequencies compared with untreated control cells. Mutation frequencies up to 27-fold higher than the spontaneous mutation frequencies were obtained. The majority of the reversion mutants contained frameshift mutations within the target sequence. However, the pattern of deletions and additions was significantly different in the two cell lines. These results indicate that oxidative damage may play a role in instability of microsatellite sequences in vivo.

    Topics: Cinnamates; DNA Damage; DNA, Neoplasm; Drug Resistance, Microbial; Frameshift Mutation; Genes, Reporter; Genetic Vectors; Humans; Hydrogen Peroxide; Hygromycin B; Lung Neoplasms; Microsatellite Repeats; Neomycin; Oxidants; Paraquat; Reactive Oxygen Species; Reading Frames; Transfection; Tumor Cells, Cultured

2000
Autocrine growth loops dependent on peptidyl alpha-amidating enzyme as targets for novel tumor cell growth inhibitors.
    Lung cancer (Amsterdam, Netherlands), 1999, Volume: 23, Issue:3

    Many small cell lung tumors are dependent in vitro and in vivo on autocrine growth loops. The prototypical small cell lung cancer autocrine growth factor, gastrin-releasing peptide (GRP), is one of many peptide hormones which require post-translational carboxy-terminal alpha-amidation for bioactivity. We have reported that neuroendocrine human lung tumor cell lines express the bifunctional enzyme PAM which catalyzes the biosynthesis of alpha-amidated peptides in a two-step process, and have recently shown that non-small cell lung cancer cell lines and tumors, generally considered to be non-endocrine in nature, also express PAM. We have also shown that two chemical classes of PAM inhibitors, substrate analogues and specific copper chelators, inhibit amidating enzyme activity in cell-free extracts. Here we demonstrate in vitro growth inhibition of lung cancer tumor cell lines by both these classes of PAM inhibitors using the MTT assay and the clonogenic assay. Growth inhibition in a small cell lung cancer cell line can be overcome by exogenous addition of synthetic alpha-amidated GRP. Similar growth-suppressive effects are seen in cell lines stably transfected with a vector expressing antisense PAM RNA. These data support the mechanism of inhibition for a new type of chemotherapeutic/intervention agent, directed at synthesis and activation of peptide growth factors, and support our postulate that alpha-amidated peptide hormones are a common component in lung tumor autocrine growth biology which can be inhibited by targeting the biochemical mechanisms necessary for growth factor synthesis.

    Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Autocrine Communication; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cell Division; Cinnamates; Culture Media, Conditioned; Ditiocarb; Dose-Response Relationship, Drug; Fatty Acids, Monounsaturated; Growth Inhibitors; Humans; Hygromycin B; Lung Neoplasms; Mixed Function Oxygenases; Multienzyme Complexes; Oligonucleotides, Antisense; Transfection; Tumor Cells, Cultured; Tumor Stem Cell Assay

1999
Chemosensitivity of micrometastases and circulating tumor cells to uracil and tegafur as evaluated using LacZ gene-tagged Lewis lung carcinoma cell.
    Cancer letters, 1999, Jul-19, Volume: 142, Issue:1

    The chemosensitivity of the sequence of steps responsible for metastasis formation including circulating tumor cells and micrometastases to a 5-fluorouracil derivative (UFT) was examined with a novel micrometastasis model featuring Lewis lung carcinoma cells tagged with the bacterial LacZ gene and hygromycinR gene (hygR). Metastases in the lung could be specifically detected at the single-cell level by X-Gal staining after inoculation of LacZ-transfected tumor cells. Spontaneous metastasis in mice bearing subcutaneous primary tumors was significantly inhibited by UFT at doses of 15-20 mg/kg when it was orally administered from day 14, during the early stage of micrometastasis formation, but not by late administration from day 22. Experimental pulmonary metastasis was also inhibited without significant toxic side effects by oral administration of UFT at a daily dose of 20 mg/kg from day 4, when the tumor cells start new growth in the lung, but not by daily treatment from 8 days after intravenous injection. Oral administration of UFT had no effect on tumor cell arrest in the lung as detected by X-Gal staining. Furthermore, PCR analysis revealed that circulating tumor cells in the peripheral blood of mice bearing primary tumors after subcutaneous injection of hygR-tagged tumor cells were significantly reduced by the oral administration of UFT for 7 days in a dose-dependent manner. These results indicate that circulating tumor cells in the peripheral blood and micrometastases in the initial growth phase in the lungs are sensitive to this chemotherapeutic agent, and suggest that micrometastasis formation can be effectively inhibited by long-term oral administration of anticancer agents with minimal toxic side effects.

    Topics: Administration, Oral; Animals; Antimetabolites, Antineoplastic; Carcinoma, Lewis Lung; Cinnamates; Hygromycin B; Lac Operon; Lung Neoplasms; Male; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Tegafur; Uracil

1999
Predominance of the metastatic phenotype in somatic cell hybrids of the K-1735 murine melanoma.
    Cancer research, 1991, Dec-01, Volume: 51, Issue:23 Pt 1

    The purpose of these studies was to determine whether the metastatic phenotype will dominate when metastatic and nonmetastatic clones of the K-1735 mouse melanoma are hybridized by somatic cell fusion. Three nonmetastatic and three metastatic clones were transfected with DNA from plasmids pSV2neo or pSV2hygro, which confer resistance to the drugs neomycin or hygromycin, respectively. The metastatic properties of the six clones were not altered by these transfections. The tumorigenicity and metastatic capacity of cell hybrids formed by somatic cell fusion of nonmetastatic and metastatic clones were examined. To do so, near-tetraploid hybrids containing a nearly complete chromosomal complement from both parental cells were injected i.v. into syngeneic mice, and the number of metastatic nodules in the lung was determined at 45 days or when the mice became moribund. Seven of nine hybrids produced from the fusion of metastatic and nonmetastatic clones exhibited a highly metastatic phenotype, although in most cases the metastatic potential of the hybrids was lower than that of the metastatic parent cells. Very similar results were obtained in athymic nude mice. The metastatic potential of the hybrids was directly correlated with their growth in the subcutis of nude mice. These results indicate that the metastatic capacity of K-1735 cells predominates in somatic cell hybrids between nonmetastatic and metastatic cells. When fusion of nonmetastatic and metastatic cells yields a hybrid with nonmetastatic properties, it may be due to suppression of growth.

    Topics: Animals; Cinnamates; Drug Resistance; Female; Hybrid Cells; Hygromycin B; Karyotyping; Lung Neoplasms; Melanoma, Experimental; Mice; Mice, Inbred C3H; Mice, Nude; Neomycin; Neoplasm Metastasis; Neoplasm Transplantation; Phenotype; Specific Pathogen-Free Organisms; Transfection; Tumor Cells, Cultured

1991